Expert Pitch
Florida State University

FSU expert available to discuss vaccine hesitancy

2-Jun-2021 4:25 PM EDT, by Florida State University

By: Bill Wellock | Published: | 1:16 pm | SHARE: Share on FacebookTweet

Rollout of the COVID-19 vaccine is continuing, but some people are hesitant to get vaccinated against the disease.

Dr. Christie Alexander, an associate professor in the Department of Family Medicine and Rural Health in the Florida State University College of Medicine and a past president of the Florida Academy of Family Physicians, recently participated in an expert panel about how to win over vaccine skeptics.

Selected questions and answers from Dr. Alexander’s participation in the expert panel have been edited for clarity and appear below:

As a family physician, what kind of questions are you hearing behind people’s vaccine hesitancy and what do you feel like we can learn from what you are hearing from patients?

“Some of the biggest things that we are hearing have to do with just how quickly people feel the vaccine was made — although we in science know that this has been a long time coming. We hear a lot in practice — ‘It’s just so quick, I want to see what happens, I want to see how other people feel when they get it’ — that sort of thing.

“The other thing I hear a lot is fear of the side effects. There has been a lot of talk about that, that fear of feeling bad for a few days after getting the vaccine and not understanding that’s the hump to get over that keeps you from getting so sick from COVID itself.

“There is also the idea that people don’t want to feel like they are guinea pigs. That goes along with how quickly they feel the vaccine was made. And then very few and far between do I personally hear conspiracy theories like ‘They’re inserting genetic materials into my system’ or things like that.”

Digging a bit further into some of the objections you’re hearing from patients, specifically the idea of people getting the vaccines now being sort of the guinea pigs — tens of thousands of subjects were part of the clinical trials, correct? That’s an extraordinarily large group to be done simultaneously around the world. Can you tell us a little bit more about that? When you speak to people, is that something you talk about?

“That is definitely something that I talk to patients about when they bring that up as a concern. Tens of thousands of people participated in clinical trials before the vaccines were authorized for emergency use. All of those people had to pass through the various phases of the trials in order for the vaccines to reach emergency use authorization by the U.S. Food and Drug Administration.

“In addition to that, with these particular vaccines, scientists have been working on variations of this for coronavirus and various other viruses for years. The thing that people have to realize is that when there’s a global pandemic, everything gets put on hold. These vaccines became the primary focus for everyone globally. Patients ask, ‘Why was it taking so long beforehand?’ That’s because we were working on other things. COVID-19 vaccines became the primary thing, the most important thing, for the health of the world.

“In addition, I’ll even use myself as the example and tell them I’ve been vaccinated and many of their healthcare workers have received it as well without any long-term problems.”

What do you say to skeptics who might say that things are ever-changing, and therefore, why not wait a little while?

“I would say that’s true — things are always changing, and if you choose to wait, I understand that but know that the risk of coronavirus is still very real. COVID-19 is very real, and we are still seeing — although the numbers are decreasing — we are still seeing deaths. So the quicker we can get people immunized, the quicker we can feel safe knowing that we are not spreading the disease, that we are controlling it so that we don’t have another hotspot or another uptick. We can protect ourselves moving into this new normal going forward.”

Filters close

Showing results

110 of 5872
Released: 24-Jun-2021 4:55 PM EDT
Virus that causes COVID-19 can find alternate route to infect cells
Washington University in St. Louis

The virus that causes COVID-19 normally gets inside cells by attaching to a protein called ACE2. Researchers at Washington University School of Medicine in St. Louis have found that a single mutation confers the ability to enter cells through another route, which may threaten the effectiveness of COVID-19 vaccines and therapeutics designed to block the standard route of entry.

Newswise: Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Released: 24-Jun-2021 3:05 PM EDT
Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Homeland Security's Science And Technology Directorate

S&T is preparing for future outbreaks/pandemics by investing in a new tech that can quickly discriminate between bacterial and viral infections so that the U.S. can triage patients and plan a response without delay.

Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Showing results

110 of 5872